Press "Enter" to skip to content

Patent delisted for Novartis drug STARLIX

0
Copyright © DrugPatentWatch. Originally published at Patent delisted for Novartis drug STARLIX

Annual Drug Patent Expirations for STARLIX
Starlix is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are two patents protecting this drug and one Paragraph IV challenge.

STARLIX drug price trends.

This drug has forty-two patent family members in thirty countries.

The generic ingredient in STARLIX is nateglinide. One supplier is listed for this compound. Additional details are available on the nateglinide profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at Patent delisted for Novartis drug STARLIX
    Do NOT follow this link or you will be banned from the site!